Tissue engineering combines cells, biomaterials, biochemical signals, and engineering design to repair, replace, model, or regenerate biological tissues. It draws on cell biology, materials science, biomechanics, bioreactors, scaffold design, and regenerative medicine to create environments where cells can organize and function. In nanotechnology and biotechnology, tissue engineering often uses nanostructured scaffolds, hydrogels, surface cues, nanoparticles, and biofabrication methods to guide cell behavior.
Tissue engineering matters because damaged tissues and organs remain difficult to repair with conventional therapies alone. Research targets bone, cartilage, skin, nerve, heart, liver, blood vessels, and complex tissue interfaces. Nanoscale features can influence cell adhesion, differentiation, matrix deposition, immune response, vascularization, and mechanical function. The field connects closely to biomaterials, regenerative medicine, scaffolds, and biofabrication.
Conferences on tissue engineering appear in biomedical engineering, biomaterials, regenerative medicine, nanomedicine, cell therapy, and biotechnology programs. Sessions often cover scaffold materials, stem cells, vascularization, bioprinting, organ models, and clinical translation. Tracking tissue-engineering events helps researchers follow how engineered biological systems are moving from laboratory constructs toward therapeutic and modeling applications.
To learn more, read our detailed glossary article on tissue engineering.